{"id":"https://openalex.org/W2252547320","doi":null,"title":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.","display_name":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.","publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2252547320","mag":"2252547320","pmid":"https://pubmed.ncbi.nlm.nih.gov/12516958"},"language":"en","primary_location":{"id":"pmid:12516958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12516958","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103543059","display_name":"Manas K. Pathak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manas K Pathak","raw_affiliation_strings":["Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019247175","display_name":"Deepika Dhawan","orcid":"https://orcid.org/0000-0002-5456-9302","observed_orcids":["https://orcid.org/0000-0002-5456-9302"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deepika Dhawan","raw_affiliation_strings":["[Cleveland Clinic Foundation]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"[Cleveland Clinic Foundation]","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011842741","display_name":"Daniel J. Lindner","orcid":"https://orcid.org/0000-0002-8296-7703","observed_orcids":["https://orcid.org/0000-0002-8296-7703"]},"institutions":[{"id":"https://openalex.org/I4390039247","display_name":"Case Comprehensive Cancer Center","ror":"https://ror.org/00fpjq451","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039247","https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J Lindner","raw_affiliation_strings":["Case Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Comprehensive Cancer Center","institution_ids":["https://openalex.org/I4390039247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112252438","display_name":"Ernest C. Borden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ernest C Borden","raw_affiliation_strings":["Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109113142","display_name":"Carol F. Farver","orcid":"https://orcid.org/0000-0002-8055-8252","observed_orcids":["https://orcid.org/0000-0002-8055-8252"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Farver","raw_affiliation_strings":["[Cleveland Clinic Foundation]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"[Cleveland Clinic Foundation]","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109917174","display_name":"Taolin Yi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taolin Yi","raw_affiliation_strings":["[Cleveland Clinic Foundation]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"[Cleveland Clinic Foundation]","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0518,"has_fulltext":false,"cited_by_count":124,"citation_normalized_percentile":{"value":0.73771838,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"1","issue":"14","first_page":"1255","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pentamidine","display_name":"pentamidine","score":1.0},{"id":"https://openalex.org/keywords/ptp1b","display_name":"PTP1B","score":0.5559999942779541},{"id":"https://openalex.org/keywords/prl2","display_name":"PRL-2","score":0.8740000128746033},{"id":"https://openalex.org/keywords/protein-tyrosine-phosphatase-inhibitors","display_name":"protein tyrosine phosphatase inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8870000243186951},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8610000014305115},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tumor-cell-necrosis","display_name":"tumor cell necrosis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2777530519","wikidata":"https://www.wikidata.org/wiki/Q416206","display_name":"Pentamidine","level":3,"score":0.6747176647186279},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5815906524658203},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5261504054069519},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46635735034942627},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4626985192298889},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.45932528376579285},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4541057050228119},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.448081910610199},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4232833981513977},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39847275614738464},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3264257609844208},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15817168354988098},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13604536652565002},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08151987195014954},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010419","descriptor_name":"Pentamidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016475","descriptor_name":"3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017027","descriptor_name":"Protein Tyrosine Phosphatases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:12516958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12516958","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.835.4252","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.835.4252","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/1/14/1255.full.pdf","raw_type":"text"},{"id":"mag:2252547320","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12516958","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1020425044","display_name":"SHP-1/TYK2 INTERACTION AND ITS DEFECT IN FHLH DISEASE","funder_award_id":"R01CA079891","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G598097664","display_name":"Increasing Effects of Interferons for Melanoma","funder_award_id":"R01CA090914","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W185106840","https://openalex.org/W1512072195","https://openalex.org/W1512405945","https://openalex.org/W1554882016","https://openalex.org/W1557658014","https://openalex.org/W1612419598","https://openalex.org/W1864739484","https://openalex.org/W1867578926","https://openalex.org/W1946170591","https://openalex.org/W1969235258","https://openalex.org/W1980400502","https://openalex.org/W1980708917","https://openalex.org/W1983797577","https://openalex.org/W1988662534","https://openalex.org/W1988833224","https://openalex.org/W1999809189","https://openalex.org/W2001471842","https://openalex.org/W2007661705","https://openalex.org/W2015998760","https://openalex.org/W2023109610","https://openalex.org/W2023212893","https://openalex.org/W2027064373","https://openalex.org/W2029285064","https://openalex.org/W2029919946","https://openalex.org/W2046195801","https://openalex.org/W2048258133","https://openalex.org/W2051077075","https://openalex.org/W2056515815","https://openalex.org/W2068133101","https://openalex.org/W2071738609","https://openalex.org/W2072018602","https://openalex.org/W2072365826","https://openalex.org/W2078102016","https://openalex.org/W2095601551","https://openalex.org/W2095662391","https://openalex.org/W2100258190","https://openalex.org/W2100869656","https://openalex.org/W2102838769","https://openalex.org/W2108125679","https://openalex.org/W2128415112","https://openalex.org/W2137573326","https://openalex.org/W2146101976","https://openalex.org/W2152123040","https://openalex.org/W2160584487","https://openalex.org/W2164355279","https://openalex.org/W2166510876","https://openalex.org/W2168062869","https://openalex.org/W2237836223","https://openalex.org/W2257356373","https://openalex.org/W2347206875","https://openalex.org/W2398229687","https://openalex.org/W2411790150","https://openalex.org/W2416406364"],"related_works":["https://openalex.org/W7096615090","https://openalex.org/W2507287985","https://openalex.org/W2468763634","https://openalex.org/W6945487443","https://openalex.org/W2074919423","https://openalex.org/W2043940323","https://openalex.org/W2099196476","https://openalex.org/W2806252581","https://openalex.org/W4298222629","https://openalex.org/W3136152515"],"abstract_inverted_index":{"The":[0,76],"PRL":[1,51],"family":[2],"oncogenic":[3],"phosphatases":[4,52],"are":[5],"attractive":[6],"targets":[7],"for":[8,145],"developing":[9,146],"inhibitors":[10],"as":[11],"anticancer":[12,42,138],"therapeutics":[13],"given":[14],"their":[15],"potentially":[16],"pathogenic":[17],"role":[18],"in":[19,53,60,79,107,126,137],"human":[20,84,104],"malignancies.":[21],"Herein":[22],"we":[23],"demonstrate":[24],"that":[25,88],"pentamidine,":[26],"an":[27,31,37,64],"anti-protozoa":[28],"drug":[29,77],"with":[30,41,63,111],"unknown":[32],"mechanism":[33],"of":[34,39,102,114,121,135],"action,":[35],"is":[36,119],"inhibitor":[38],"PRLs":[40,59],"potential.":[43],"Pentamidine":[44,93],"at":[45,94],"its":[46],"therapeutic":[47],"doses":[48],"inhibited":[49,99],"recombinant":[50],"vitro":[54,80],"and":[55,118,140],"inactivated":[56],"ectopically":[57,123],"expressed":[58,124],"NIH3T3":[61],"transfectants":[62],"effective":[65],"duration":[66],"more":[67],"than":[68],"24":[69],"h":[70],"after":[71],"a":[72,95,143],"pulse":[73],"cell":[74,86,116],"treatment.":[75],"had":[78],"growth-inhibitory":[81],"activity":[82],"against":[83],"cancer":[85,128],"lines":[87],"express":[89],"the":[90,100,112,127,133],"endogenous":[91],"PRLs.":[92],"tolerable":[96],"dose":[97],"markedly":[98],"growth":[101],"WM9":[103],"melanoma":[105],"tumors":[106],"nude":[108],"mice":[109],"coincident":[110],"induction":[113],"tumor":[115],"necrosis":[117],"capable":[120],"inactivating":[122],"PRL-2":[125],"cells.":[129],"These":[130],"observations":[131],"suggest":[132],"potential":[134],"pentamidine":[136],"therapies":[139],"may":[141],"provide":[142],"basis":[144],"novel":[147],"PTPase-targeted":[148],"therapeutics.":[149]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}